XML 73 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 27, 2023
USD ($)
$ / shares
shares
May 22, 2022
shares
Nov. 22, 2021
shares
Sep. 20, 2021
USD ($)
item
$ / shares
shares
Apr. 18, 2021
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
item
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
item
shares
Dec. 02, 2020
shares
Aug. 04, 2020
shares
Oct. 31, 2010
$ / shares
shares
Stockholders' Equity [Line Items]                          
Common Stock Shares Authorized               1,000,000,000 1,000,000,000       1,000,000,000
Common Stock Par Or Stated Value Per Share | $ / shares               $ 0.001 $ 0.001       $ 0.001
Preferred Stock Shares Authorized               50,000,000 50,000,000       50,000,000
Preferred Stock Par Or Stated Value Per Share | $ / shares               $ 0.001 $ 0.001       $ 0.001
Preferred Stock Shares Issued               0 0        
Preferred Stock Shares Outstanding               0 0        
Common stock, dividends declared | $ / shares               $ 0          
Voting right of common stock share holders               one          
Voting right of common stock share holders, number of votes | item               1          
Proceeds From Issuance Of Common Stock | $               $ 11,230 $ 31,806 $ 46,360      
Vested and exercisable options               22,700,000          
Weighted average remaining contractual life for exercisable               5 years 4 months 24 days          
Vested and expected to vest, aggregate intrinsic value | $               $ 24,600          
Vested and expected to vest, weighted average exercise price | $ / shares               $ 10.61          
Vested and expected to vest, weighted average remaining contractual life               6 years 6 months          
Total intrinsic value of options exercised | $               $ 5,000 146,100 $ 63,100      
Stock-based compensation cost capitalized in inventory | $               $ 700 $ 900        
Dividend yield               0.00%          
Weighted average grant date fair value per share | $ / shares               $ 5.93 $ 18.36 $ 4.14      
Common Stock Shares Issued               226,505,000 220,978,000        
Private Placement of Common Stock [Member]                          
Stockholders' Equity [Line Items]                          
Proceeds From Issuance Of Common Stock | $       $ 300,000                  
Price per share | $ / shares       $ 26.75                  
Common Stock Shares Issued       11,214,953                  
Common Stock [Member]                          
Stockholders' Equity [Line Items]                          
Shares issued                   29,356,000      
Omniome Plan [Member]                          
Stockholders' Equity [Line Items]                          
Exchange ratio | item       0.259204639                  
Shares authorized       2,494,128                  
2010 Plan [Member]                          
Stockholders' Equity [Line Items]                          
Common stock remain available for issuance               25,500,000          
ESPP [Member]                          
Stockholders' Equity [Line Items]                          
Common stock remain available for issuance               9,932,505          
Percentage of outstanding common stock used to determine annual plan increase               2.00%          
Number of purchase periods | item               4          
Purchase period of ESPP               6 months          
Percentage of fair market value at which stock can be purchased               85.00%          
Common stock purchased under plan               1,878,168 1,913,968 834,677      
Cash received from option exercises | $               $ 7,800 $ 6,400 $ 2,400      
Weighted-average grant-date fair value of all RSUs granted | $ / shares               $ 4.28 $ 25.07 $ 1.87      
Common Stock Shares Issued               4,000,000          
2020 Equity Incentive Plan [Member]                          
Stockholders' Equity [Line Items]                          
Shares authorized                       11,000,000  
Additional common stock reserved for issuance   18,000,000                      
2020 Inducement Equity Incentive Plan [Member]                          
Stockholders' Equity [Line Items]                          
Shares authorized                     2,500,000    
Additional common stock reserved for issuance     360,000   750,000                
Common stock remain available for issuance               18,900,000          
Underwritten Public Equity Offering [Member]                          
Stockholders' Equity [Line Items]                          
Shares issued                   29,400,000      
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $                   $ 187,200      
Number of offerings | item               2   2      
Price per share | $ / shares                   $ 6.40      
Underwriting Agreement [Member]                          
Stockholders' Equity [Line Items]                          
Common Stock Par Or Stated Value Per Share | $ / shares           $ 0.001 $ 0.001            
Public offering           6,096,112 19,430,000            
Common stock offering price per share | $ / shares           $ 14.25 $ 4.47            
Public offering, option to purchase additional shares, period           30 days 30 days            
Public offering, option to purchase additional shares, shares           914,416 2,914,500            
Shares issued           7,000,000.0 22,300,000            
Commissions, percentage of gross proceeds           6.00% 6.00%            
Proceeds from issuance of common stock from underwritten public equity offerings, net of issuance costs | $           $ 93,900 $ 93,900            
Offering costs | $           $ 300 $ 300            
Time-based and performance-based options [Member]                          
Stockholders' Equity [Line Items]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number               9,408,063          
Options expired, weighted average exercise price | $ / shares               $ 8.45          
Aggregate intrinsic value outstanding | $               $ 24,700          
Weighted average remaining contractual life               6 years 8 months 12 days          
Vested and expected to vest, outstanding               14,436,695          
RSUs With Time-Based Vesting [Member]                          
Stockholders' Equity [Line Items]                          
Ratio of number of shares into which the share instrument may be converted               1          
Vesting period               4 years          
Weighted-average grant-date fair value of all RSUs granted | $ / shares               $ 10.15 $ 35.33 $ 5.18      
Total fair value of shares vested related to RSUs | $               $ 39,200 $ 9,200 $ 6,300      
Options To Purchase Common Stock [Member]                          
Stockholders' Equity [Line Items]                          
Stock price | $ / shares               $ 8.18          
Unrecognized compensation costs | $               $ 125,100          
Cash received from option exercises | $               $ 3,400 $ 25,400 $ 43,900      
Weighted average grant date fair value per share | $ / shares               $ 5.93 $ 15.53 $ 7.20      
Options To Purchase Common Stock [Member] | Common Stock [Member]                          
Stockholders' Equity [Line Items]                          
Weighted average remaining contractual life               2 years 4 months 24 days          
Subsequent Event [Member]                          
Stockholders' Equity [Line Items]                          
Proceeds From Issuance Of Common Stock | $ $ 201,300                        
Price per share | $ / shares $ 10.00                        
Common Stock Shares Issued 20,125,000                        
Share-based Compensation Award, Tranche One, Two, Three and Four [Member] | RSUs With Time-Based Vesting [Member]                          
Stockholders' Equity [Line Items]                          
Vesting percentage               25.00%